Shopping Cart
- Remove All
- Your shopping cart is currently empty
TFCP2L1-IN-1 is a specific small molecule that targets the active region of TFCP2L1 and exhibits anticancer activity. It synergizes with Sorafenib to induce cell apoptosis (Apoptosis) and reduces proliferation, invasion, metastasis, clonogenicity, and spheroid formation capabilities in liver cancer cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | TFCP2L1-IN-1 is a specific small molecule that targets the active region of TFCP2L1 and exhibits anticancer activity. It synergizes with Sorafenib to induce cell apoptosis (Apoptosis) and reduces proliferation, invasion, metastasis, clonogenicity, and spheroid formation capabilities in liver cancer cells. |
Molecular Weight | 349.25 |
Formula | C15H13BrN2OS |
Cas No. | 364621-46-5 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.